Literature DB >> 311246

Vincristine effect on methotrexate cerebrospinal fluid concentration.

F Tejada, C G Zubrod.   

Abstract

A 67-year-old man with malignant lymphoma, nodular, poorly differentiated lymphocytic type, developed meningeal lymphomatosis. Repeated high-dose methotrexate-citrovorum factor treatment (1 g/m2 in 24 hours) rendered the patient free of disease. The administration of vincristine at 23 hours consistently increased the concentration of methotrexate in the cerebrospinal fluid 2.5-fold above baseline values.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311246

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  4 in total

Review 1.  Pharmacokinetic considerations in the treatment of CNS tumours.

Authors:  Susannah Motl; Yanli Zhuang; Christopher M Waters; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Methotrexate-vindesine association in leukemia: pharmacokinetic study.

Authors:  N Tubiana; N Lena; J Barbet; A M Imbert; C Lejeune; D Maraninchi; D Sainty; G Sebahoun; J A Gastaut; J P Cano
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.

Authors:  E Smeland; R M Bremnes; A Bessesen; R Jaeger; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 4.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.